These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3932794)

  • 1. Hyperthyroidism. Causes, clinical features, and diagnosis.
    Spaulding SW; Lippes H
    Med Clin North Am; 1985 Sep; 69(5):937-51. PubMed ID: 3932794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.
    Walfish PG; Gottesman IS; Baxter JL
    Can Med Assoc J; 1982 Aug; 127(4):291-4. PubMed ID: 6807523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
    Wiersinga WM; Smit T; van der Gaag R; Koornneef L
    J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of pituitary response to thyrotrophin-releasing hormone in euthyroid Graves' disease.
    Lawton NF; Ekins RP; Nabarro JD
    Lancet; 1971 Jul; 2(7714):14-6. PubMed ID: 4103663
    [No Abstract]   [Full Text] [Related]  

  • 10. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretibial myxedema: pathophysiology and treatment options.
    Fatourechi V
    Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment and management of hyperthyroidism.
    Waldstein SS
    Otolaryngol Clin North Am; 1980 Feb; 13(1):13-27. PubMed ID: 6154274
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthyroidism: diagnosis and treatment.
    Reid JR; Wheeler SF
    Am Fam Physician; 2005 Aug; 72(4):623-30. PubMed ID: 16127951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of hyperthyroidism and ophthalmopathy following hypothyroidism].
    Kálmán K; Nagy E; Leövey A
    Orv Hetil; 1990 Jul; 131(27):1481-3. PubMed ID: 2377370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
    Momotani N; Noh J; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):285-9. PubMed ID: 7913091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
    Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
    Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' disease and selective resistance of pituitary thyrotroph to thyroid hormone. A case report.
    Pillay NL; Jialal I; Govender PA; Green-Thompson RW; Joubert SM
    S Afr Med J; 1986 Sep; 70(6):360-1. PubMed ID: 3092372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations.
    Sandler R
    J Clin Endocrinol Metab; 1976 Jan; 42(1):163-8. PubMed ID: 814132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.